In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex

Detalhes bibliográficos
Autor(a) principal: Paixão, Drielly A.
Data de Publicação: 2019
Outros Autores: Lopes, Carla D., Carneiro, Zumira A., Sousa, Luana M., de Oliveira, Leticia P., Lopes, Norberto P., Pivatto, Marcos, Chaves, Joana Darc S., de Almeida, Mauro V., Ellena, Javier, Moreira, Mariete B. [UNESP], Netto, Adelino V.G. [UNESP], de Oliveira, Ronaldo J., Guilardi, Silvana, de Albuquerque, Sérgio, Guerra, Wendell
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.biopha.2018.10.057
http://hdl.handle.net/11449/189671
Resumo: In order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4′-dimethoxy-2-2′-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO 4 ) 2 ], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO 4 ) 2 ] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with K b values in the range of 10 3 –10 4 M –1 , with [Cu(4-MH)(dmb)(ClO 4 ) 2 ] showing the highest K b value (1.45 × 10 4 M –1 ). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO 4 ) 2 ] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond.
id UNSP_eb10036991b54a30c4206999850ea109
oai_identifier_str oai:repositorio.unesp.br:11449/189671
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complexChagas diseaseCu(II) complexesDNA bindingHydrazidesMolecular dockingT. cruziIn order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4′-dimethoxy-2-2′-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO 4 ) 2 ], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO 4 ) 2 ] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with K b values in the range of 10 3 –10 4 M –1 , with [Cu(4-MH)(dmb)(ClO 4 ) 2 ] showing the highest K b value (1.45 × 10 4 M –1 ). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO 4 ) 2 ] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond.Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)Instituto de Química Universidade Federal de Uberlândia, Campus Santa MônicaDepartamento de Análises Clínicas Toxicológicas e Bromatológicas Faculdade de Ciências Farmacêuticas de Ribeirão Preto Universidade de São PauloNúcleo de Pesquisa em Produtos Naturais e Sintéticos (NPPNS) Faculdade de Ciências Farmacêuticas de Ribeirão Preto Universidade de São PauloDepartamento de Química Universidade Federal de Juiz de Fora Juiz de Fora-MGInstituto de Física de São Carlos Universidade de São PauloUNESP - Universidade Estadual Paulista Instituto de QuímicaDepartamento de Física Instituto de Ciências Exatas Naturais e Educação Universidade Federal do Triângulo MineiroUNESP - Universidade Estadual Paulista Instituto de QuímicaFAPEMIG: APQ-00330-14Universidade Federal de Uberlândia (UFU)Universidade de São Paulo (USP)Juiz de Fora-MGUniversidade Estadual Paulista (Unesp)Universidade Federal do Triângulo MineiroPaixão, Drielly A.Lopes, Carla D.Carneiro, Zumira A.Sousa, Luana M.de Oliveira, Leticia P.Lopes, Norberto P.Pivatto, MarcosChaves, Joana Darc S.de Almeida, Mauro V.Ellena, JavierMoreira, Mariete B. [UNESP]Netto, Adelino V.G. [UNESP]de Oliveira, Ronaldo J.Guilardi, Silvanade Albuquerque, SérgioGuerra, Wendell2019-10-06T16:48:23Z2019-10-06T16:48:23Z2019-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article157-166http://dx.doi.org/10.1016/j.biopha.2018.10.057Biomedicine and Pharmacotherapy, v. 109, p. 157-166.1950-60070753-3322http://hdl.handle.net/11449/18967110.1016/j.biopha.2018.10.0572-s2.0-85055895361Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBiomedicine and Pharmacotherapyinfo:eu-repo/semantics/openAccess2021-10-22T21:15:51Zoai:repositorio.unesp.br:11449/189671Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-22T21:15:51Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
title In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
spellingShingle In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
Paixão, Drielly A.
Chagas disease
Cu(II) complexes
DNA binding
Hydrazides
Molecular docking
T. cruzi
title_short In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
title_full In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
title_fullStr In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
title_full_unstemmed In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
title_sort In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
author Paixão, Drielly A.
author_facet Paixão, Drielly A.
Lopes, Carla D.
Carneiro, Zumira A.
Sousa, Luana M.
de Oliveira, Leticia P.
Lopes, Norberto P.
Pivatto, Marcos
Chaves, Joana Darc S.
de Almeida, Mauro V.
Ellena, Javier
Moreira, Mariete B. [UNESP]
Netto, Adelino V.G. [UNESP]
de Oliveira, Ronaldo J.
Guilardi, Silvana
de Albuquerque, Sérgio
Guerra, Wendell
author_role author
author2 Lopes, Carla D.
Carneiro, Zumira A.
Sousa, Luana M.
de Oliveira, Leticia P.
Lopes, Norberto P.
Pivatto, Marcos
Chaves, Joana Darc S.
de Almeida, Mauro V.
Ellena, Javier
Moreira, Mariete B. [UNESP]
Netto, Adelino V.G. [UNESP]
de Oliveira, Ronaldo J.
Guilardi, Silvana
de Albuquerque, Sérgio
Guerra, Wendell
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de Uberlândia (UFU)
Universidade de São Paulo (USP)
Juiz de Fora-MG
Universidade Estadual Paulista (Unesp)
Universidade Federal do Triângulo Mineiro
dc.contributor.author.fl_str_mv Paixão, Drielly A.
Lopes, Carla D.
Carneiro, Zumira A.
Sousa, Luana M.
de Oliveira, Leticia P.
Lopes, Norberto P.
Pivatto, Marcos
Chaves, Joana Darc S.
de Almeida, Mauro V.
Ellena, Javier
Moreira, Mariete B. [UNESP]
Netto, Adelino V.G. [UNESP]
de Oliveira, Ronaldo J.
Guilardi, Silvana
de Albuquerque, Sérgio
Guerra, Wendell
dc.subject.por.fl_str_mv Chagas disease
Cu(II) complexes
DNA binding
Hydrazides
Molecular docking
T. cruzi
topic Chagas disease
Cu(II) complexes
DNA binding
Hydrazides
Molecular docking
T. cruzi
description In order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4′-dimethoxy-2-2′-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO 4 ) 2 ], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO 4 ) 2 ] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with K b values in the range of 10 3 –10 4 M –1 , with [Cu(4-MH)(dmb)(ClO 4 ) 2 ] showing the highest K b value (1.45 × 10 4 M –1 ). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO 4 ) 2 ] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-06T16:48:23Z
2019-10-06T16:48:23Z
2019-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.biopha.2018.10.057
Biomedicine and Pharmacotherapy, v. 109, p. 157-166.
1950-6007
0753-3322
http://hdl.handle.net/11449/189671
10.1016/j.biopha.2018.10.057
2-s2.0-85055895361
url http://dx.doi.org/10.1016/j.biopha.2018.10.057
http://hdl.handle.net/11449/189671
identifier_str_mv Biomedicine and Pharmacotherapy, v. 109, p. 157-166.
1950-6007
0753-3322
10.1016/j.biopha.2018.10.057
2-s2.0-85055895361
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Biomedicine and Pharmacotherapy
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 157-166
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1792961842857902080